For licensed healthcare professionals. The protocol figures below are drawn from published labeling and peer-reviewed literature for educational reference. They are not a prescription, not a recommendation, and not a substitute for the dispensing pharmacy's labeling or your own clinical judgment.

Longevity

NAD+

aka Nicotinamide Adenine Dinucleotide

Not WADA-listed

Coenzyme central to redox metabolism and sirtuin signaling. Compounded injectable form used off-label for energy/longevity.

At a glance

Common vial size: 500 mg
Reference dose: 100 mg
Frequency: 1–3× weekly

Reference titration protocol

50 → 75 → 100 mg, +25 mg per week, once daily.

Reference titration ladder for NAD+
Step	Dose	Duration	Administrations / week
1	50 mg	1 weeks	7×
2	75 mg	1 weeks	7×
3	100 mg	1 weeks	7×

Reconstitution example

A 500 mg vial reconstituted with 3 mL of bacteriostatic water yields 166.667 mg/mL. Confirm the diluent and volume against the labeling that ships with the vial.

Open this configuration in the calculator

Clinical notes

Large vials — use 5 mL+ BAC water for workable concentration

Available formulations

Presentations carried across the VitaRelay pharmacy network, including 503A compounded, 503B outsourcing facility, and research & development sourcing. Pricing and state-level availability are shown to verified accounts only.

Injectable503A
Lyophilized PowderRUO
Lyophilized Powder503B
Nasal Spray503A
Nasal StripsRUO
Pen503B

References

Rajman et al., Cell Metabolism 2018

Often used with

Compounds commonly discussed alongside NAD+ in published protocols and prescriber requests. Listed for reference only — not a clinical recommendation, and not a suggestion to co-administer.

Pricing and ordering are for verified accounts

VitaRelay serves licensed practices, prescribers, and pharmacies. Catalog pricing, availability by state, and ordering are available after your account is verified.

Also in Longevity

Epithalon

Tetrapeptide studied in Russian gerontology for telomerase activation and pineal regulation. Human data limited to small studies.

Rapamycin

mTOR inhibitor FDA-approved as an immunosuppressant; off-label longevity dosing typically intermittent low-dose oral.

Humanin

Mitochondrial-derived peptide implicated in cytoprotection, insulin sensitivity, and neuronal survival. Early-stage research.

DSIP

Nonapeptide studied for sleep architecture, stress modulation, and pain. Limited modern human trial data.

Glutathione

Major endogenous antioxidant tripeptide. Compounded injectable and IV forms often paired with NAD+ protocols.

Educational information for licensed healthcare professionals

The material on this page is general educational information intended for licensed healthcare professionals and their clinical staff. It is not medical advice, is not a substitute for professional judgment, and does not establish a provider-patient relationship. Nothing here should be read as a recommendation for, or endorsement of, any specific therapy, product, or course of treatment. Compounded preparations must be handled in accordance with applicable federal and state law, the dispensing pharmacy's labeling, and your own institutional policies. All clinical decisions — including product selection, preparation, dosing, and administration — remain the sole responsibility of the treating licensed practitioner.

VitaRelay is a technology and logistics network. We are not a pharmacy, prescriber, or distributor. See our Terms of Service and service availability for details.